• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质酪氨酸磷酸酶:结构、作用机制及抑制剂的发现

Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.

作者信息

Burke T R, Zhang Z Y

机构信息

Laboratory of Medicinal Chemistry, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Biopolymers. 1998;47(3):225-41. doi: 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O.

DOI:10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O
PMID:9817026
Abstract

Protein-tyrosine kinases (PTKs) and their associated signaling pathways are crucial for the regulation of numerous cell functions including growth, mitogenesis, motility, cell-cell interactions, metabolism, gene transcription, and the immune response. Since tyrosine phosphorylation is reversible and dynamic in vivo, the phosphorylation states of proteins are governed by the opposing actions of PTKs and protein-tyrosine phosphatases (PTPs). In this light, both PTKs and PTPs play equally important roles in signal transduction in eukaryotic cells, and comprehension of mechanisms behind the reversible pTyr-dependent modulation of protein function and cell physiology must necessarily encompass the characterization of PTPs as well as PTKs. In spite of the large number of PTPs identified to date and the emerging role played by PTPs in disease, a detailed understanding of the role played by PTPs in signaling pathways has been hampered by the absence of PTP-specific agents. Such PTP-specific inhibitors could potentially serve as useful tools in determining the physiological significance of protein tyrosine phosphorylation in complex cellular signal transduction pathways and may constitute valuable therapeutics in the treatment of several human diseases. The goal of this review is therefore to summarize current understandings of PTP structure and mechanism of catalysis and the relationship of these to PTP inhibitor development. The review is organized such that enzyme structure is covered first, followed by mechanisms of catalysis then PTP inhibitor development. In discussing PTP inhibitor development, nonspecific inhibitors and those obtained by screening methods are initially presented with the focus then shifting to inhibitors that utilize a more structure-based rationale.

摘要

蛋白酪氨酸激酶(PTKs)及其相关信号通路对于调节众多细胞功能至关重要,这些功能包括生长、有丝分裂、运动、细胞间相互作用、代谢、基因转录和免疫反应。由于酪氨酸磷酸化在体内是可逆且动态的,蛋白质的磷酸化状态受PTKs和蛋白酪氨酸磷酸酶(PTPs)的相反作用支配。因此,PTKs和PTPs在真核细胞信号转导中发挥着同等重要的作用,要理解蛋白质功能和细胞生理学中依赖于酪氨酸磷酸化的可逆调节背后的机制,必然需要对PTPs以及PTKs进行表征。尽管迄今为止已鉴定出大量的PTPs,且PTPs在疾病中发挥着越来越重要的作用,但由于缺乏PTP特异性试剂,对PTPs在信号通路中所起作用的详细了解受到了阻碍。这种PTP特异性抑制剂可能会成为确定复杂细胞信号转导通路中蛋白质酪氨酸磷酸化生理意义的有用工具,并可能成为治疗多种人类疾病的有价值的治疗方法。因此,本综述的目的是总结目前对PTP结构、催化机制以及它们与PTP抑制剂开发之间关系的理解。综述的组织方式是首先介绍酶结构,接着是催化机制,然后是PTP抑制剂开发。在讨论PTP抑制剂开发时,首先介绍非特异性抑制剂和通过筛选方法获得的抑制剂,然后将重点转向基于更合理结构的抑制剂。

相似文献

1
Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.蛋白质酪氨酸磷酸酶:结构、作用机制及抑制剂的发现
Biopolymers. 1998;47(3):225-41. doi: 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O.
2
Proteomic approaches to studying protein tyrosine phosphatases.用于研究蛋白质酪氨酸磷酸酶的蛋白质组学方法。
Mol Biosyst. 2007 May;3(5):308-16. doi: 10.1039/b700704n. Epub 2007 Mar 21.
3
Src homology-2 domains: structure, mechanisms, and drug discovery.Src同源2结构域:结构、机制与药物研发
Biopolymers. 1998;47(3):243-61. doi: 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P.
4
Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.基于肽的信号转导抑制剂设计中的磷酸化酪氨酸模拟物
Biopolymers. 2001;60(1):32-44. doi: 10.1002/1097-0282(2001)60:1<32::AID-BIP1002>3.0.CO;2-I.
5
Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.蛋白质酪氨酸磷酸酶研究的化学和机制方法。
Acc Chem Res. 2003 Jun;36(6):385-92. doi: 10.1021/ar020122r.
6
MAPK-specific tyrosine phosphatases: new targets for drug discovery?丝裂原活化蛋白激酶特异性酪氨酸磷酸酶:药物研发的新靶点?
Trends Pharmacol Sci. 2006 Oct;27(10):525-30. doi: 10.1016/j.tips.2006.08.005. Epub 2006 Aug 21.
7
Allele-specific inhibitors of protein tyrosine phosphatases.蛋白酪氨酸磷酸酶的等位基因特异性抑制剂。
J Am Chem Soc. 2005 Mar 9;127(9):2824-5. doi: 10.1021/ja043378w.
8
Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.不带电荷的硫代噻唑烷酮衍生物对蛋白酪氨酸磷酸酶1B的细胞抑制作用。
Chembiochem. 2007 Jan 22;8(2):179-86. doi: 10.1002/cbic.200600287.
9
Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.过氧化氢对蛋白酪氨酸磷酸酶的特异性可逆失活:亚磺酸中间体的证据及其对氧化还原调节的意义。
Biochemistry. 1998 Apr 21;37(16):5633-42. doi: 10.1021/bi973035t.
10
Inhibitors of protein tyrosine phosphatases: next-generation drugs?蛋白酪氨酸磷酸酶抑制剂:新一代药物?
Angew Chem Int Ed Engl. 2005 Jun 20;44(25):3814-39. doi: 10.1002/anie.200461517.

引用本文的文献

1
Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma.抑制信号转导与转录激活因子3(STAT3):提高髓母细胞瘤化疗疗效的一种有前景的方法。
Transl Oncol. 2024 Aug;46:102023. doi: 10.1016/j.tranon.2024.102023. Epub 2024 Jun 8.
2
Rubrofusarin as a Dual Protein Tyrosine Phosphate 1B and Human Monoamine Oxidase-A Inhibitor: An in Vitro and in Silico Study.红镰菌素作为双靶点蛋白酪氨酸磷酸酶1B和人单胺氧化酶-A抑制剂的体外和计算机模拟研究
ACS Omega. 2019 Jul 3;4(7):11621-11630. doi: 10.1021/acsomega.9b01433. eCollection 2019 Jul 31.
3
Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.
系统性硬化症中的蛋白酪氨酸磷酸酶:潜在的致病因素和治疗靶点
Curr Rheumatol Rep. 2017 May;19(5):28. doi: 10.1007/s11926-017-0655-7.
4
Cell Transformation by PTP1B Truncated Mutants Found in Human Colon and Thyroid Tumors.在人类结肠和甲状腺肿瘤中发现的蛋白酪氨酸磷酸酶1B截短突变体导致的细胞转化
PLoS One. 2016 Nov 17;11(11):e0166538. doi: 10.1371/journal.pone.0166538. eCollection 2016.
5
Conservative tryptophan mutants of the protein tyrosine phosphatase YopH exhibit impaired WPD-loop function and crystallize with divanadate esters in their active sites.蛋白质酪氨酸磷酸酶YopH的保守色氨酸突变体表现出WPD环功能受损,且在其活性位点与二钒酸酯形成晶体。
Biochemistry. 2015 Oct 27;54(42):6490-500. doi: 10.1021/acs.biochem.5b00496. Epub 2015 Oct 14.
6
Inactivation and unfolding of protein tyrosine phosphatase from Thermus thermophilus HB27 during urea and guanidine hydrochloride denaturation.嗜热栖热菌HB27蛋白酪氨酸磷酸酶在尿素和盐酸胍变性过程中的失活与去折叠
PLoS One. 2014 Sep 25;9(9):e107932. doi: 10.1371/journal.pone.0107932. eCollection 2014.
7
Cellular biochemistry methods for investigating protein tyrosine phosphatases.用于研究蛋白质酪氨酸磷酸酶的细胞生物化学方法。
Antioxid Redox Signal. 2014 May 10;20(14):2160-78. doi: 10.1089/ars.2013.5731. Epub 2014 Feb 25.
8
Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.芳基膦酸是 Cdc25a 和 Cdc25b 磷酸酶的有效且同工型选择性抑制剂。
Bioorg Med Chem. 2012 Jul 15;20(14):4371-6. doi: 10.1016/j.bmc.2012.05.040. Epub 2012 May 24.
9
Identification of novel, less toxic PTP-LAR inhibitors using in silico strategies: pharmacophore modeling, SADMET-based virtual screening and docking.利用计算策略鉴定新型、低毒的 PTP-LAR 抑制剂:药效团建模、基于 SADMET 的虚拟筛选和对接。
J Mol Model. 2012 Jan;18(1):187-201. doi: 10.1007/s00894-011-1037-0. Epub 2011 Apr 27.
10
Determination of the substrate specificity of protein-tyrosine phosphatase TULA-2 and identification of Syk as a TULA-2 substrate.测定蛋白酪氨酸磷酸酶 TULA-2 的底物特异性,并鉴定 Syk 为 TULA-2 的底物。
J Biol Chem. 2010 Oct 8;285(41):31268-76. doi: 10.1074/jbc.M110.114181. Epub 2010 Jul 29.